GLP-3 RT
Buy 4 get 1 free
$89.99
In stock
Dilution notice
If a compound turns cloudy after it is reconstituted, the cause is almost always the reconstitution solution rather than the compound itself, and non-laboratory-grade solutions are the usual culprit. For this reason, cloudiness cannot be accepted as grounds for a refund unless the reconstitution was done using a laboratory-grade reconstitution solution.
Description
Retatrutide is a peptide studied as a triple receptor agonist, engineered to engage the GLP-1, GIP, and glucagon receptors. It is researched for the structural basis of its simultaneous activity across all three receptors.
Research context
- Studied for metabolic regulation through triple-hormone signaling1
- Researched for body-weight and appetite-related biology1
- Investigated for liver-fat and cardiometabolic pathways2
CAS number 2381089-83-2
- Jastreboff AM, et al. N Engl J Med. 2023. DOI:10.1056/NEJMoa2301972
- Retatrutide MASLD phase 2a. Nat Med. 2024. DOI:10.1038/s41591-024-03018-2
Intended use
Research Use Only. Supplied strictly for laboratory research. Not for use in humans or animals, and not for use in foods, drugs, supplements, or diagnostics.
These statements have not been evaluated by the Food and Drug Administration. No claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. Use is restricted to qualified research professionals.
Batch Documentation
Independent Testing History
Review the latest independently tested batch records for this compound.
Keep exploring
